	US 12,478,679 B2
	Pharmaceutical carrier for active substances and a pharmaceutical composition containing said carrier
Pawel Biernat, Wroclaw (PL); and Jan Meler, Smolec (PL)
Assigned to BIOTTS S A, Wroclaw (PL)
Appl. No. 17/420,133
Filed by BIOTTS S A, Wroclaw (PL)
PCT Filed Jan. 10, 2020, PCT No. PCT/PL2020/050003 § 371(c)(1), (2) Date Jun. 30, 2021, PCT Pub. No. WO2020/145833, PCT Pub. Date Jul. 16, 2020.
Claims priority of application No. 428534 (PL), filed on Jan. 10, 2019.
Prior Publication US 2022/0062422 A1, Mar. 3, 2022
Int. Cl. A61K 47/20 (2006.01); A61K 9/06 (2006.01); A61K 36/718 (2006.01); A61K 36/9066 (2006.01); A61K 47/18 (2017.01); A61K 47/22 (2006.01); A61K 47/44 (2017.01)

CPC A61K 47/20 (2013.01) [A61K 9/06 (2013.01); A61K 36/718 (2013.01); A61K 36/9066 (2013.01); A61K 47/18 (2013.01); A61K 47/22 (2013.01); A61K 47/44 (2013.01)]

10 Claims

1. A pharmaceutical homogeneous carrier for both water-soluble active substances and fat-soluble active substances, characterized in that it contains:

a) a sulfoxide in an amount of 0.01% to 5% by weight,

b) a carbonic acid amide in an amount of 0.01% to 2% by weight, and

c) a vegetable oil selected from the group consisting of Chaulmoogra oil, linseed oil, rapeseed oil, peanut oil, sunflower oil, and hemp oil in an amount of 1% to 5% by weight;

wherein vitamin C dissolves in the carrier at 40° C. and vitamin A dissolves in the carrier at room temperature.